An Interethnic Comparison of Polymorphisms of the Genes Encoding Drug-Metabolizing Enzymes and Drug Transporters: Experience in Singapore
- 1 January 2005
- journal article
- review article
- Published by Taylor & Francis Ltd in Drug Metabolism Reviews
- Vol. 37 (2), 327-378
- https://doi.org/10.1081/dmr-28805
Abstract
Much of the interindividual variability in drug response is attributable to the presence of single nucleotide polymorphisms (SNPs) in genes encoding drug-metabolizing enzymes and drug transporters. In recent years, we have investigated the polymorphisms in a number of genes encoding phase I and II drug-metabolizing enzymes including CYP1A1, CYP3A4, CYP3A5, GSTM1, NAT2, UGT1A1, and TPMT and drug transporter (MDR1) in three distinct Asian populations in Singapore, namely the Chinese, Malays, and Indians. Significant differences in the frequencies of common alleles encoding these proteins have been observed among these three ethnic groups. For example, the frequency of the variant A2455G polymorphism of CYP1A1 was 28% in Chinese and 31% in Malays, but only 18% in Indians. CYP3A4*4 was detected in two of 110 Chinese subjects, but absent in Indians and Malays. Many Chinese and Malays (61–63%) were homozygous for the GSTM1*0 null genotype compared with 33% of Indians. The frequency of the UGT1A1*28 allele was highest in the Indian population (35%) compared to similar frequencies that were found in the Chinese (16%) and Malay (19%) populations. More importantly, our experience over the years has shown that the pharmacogenetics of these drug-metabolizing enzymes and MDR1 in the Asian populations are different from these in the Caucasian and African populations. For example, the CYP3A4*1B allele, which contains an A-290G substitution in the promoter region of CYP3A4, is absent in all three Asian populations of Singapore studied, but occurs in more than 54% of Africans and 5% of Caucasians. There were no difference in genotype and allelic variant frequencies in exon 12 of MDR1 between the Chinese, Malay, and Indian populations. When compared with other ethnic groups, the distribution of the wild-type C allele in exon 12 in the Malays (34.2%) and Indians (32.8%) was relatively high and similar to the Japanese (38.5%) and Caucasians (41%) but different from African–Americans (15%). The frequency of wild-type TT genotype in Asians (43.5% to 52.1%) andJapanese (61.5%) was much higher than those found in Caucasians (13.3%) All the proteins we studied represent the primary hepatic or extrahepatic enzymes, and their polymorphic expression may be implicated in disease risk and the disposition of drugs or endogenous substances. As such, dose requirements of certain drugs may not be optimal for Asian populations, and a second look at the factors responsible for this difference is necessary.This publication has 110 references indexed in Scilit:
- Polymorphisms in the CYP1A1 gene are associated with prostate cancer riskInternational Journal of Cancer, 2003
- CYP1A1 T3801 C polymorphism and lung cancer: A pooled analysis of 2,451 cases and 3,358 controlsInternational Journal of Cancer, 2003
- CYP1A1, GSTM1, and GSTT1 polymorphisms and breast cancer risk in Brazilian womenCancer Letters, 2002
- Human Aryl Hydrocarbon Receptor Polymorphisms That Result in Loss of CYP1A1 InductionBiochemical and Biophysical Research Communications, 2001
- Initial sequencing and analysis of the human genomeNature, 2001
- Interindividual Differences in Hepatic Expression of CYP3A4: Relationship to Genetic Polymorphism in the 5′-Upstream Regulatory RegionBiochemical and Biophysical Research Communications, 1999
- Correlation between P450 CYP1A1 inducibility, Mspi genotype and lung cancer incidenceEuropean Journal of Cancer, 1996
- Preliminary phenotypic map of chromosome 4p16 based on 4p deletionsAmerican Journal of Medical Genetics, 1995
- Altered mercaptopurine metabolism, toxic effects, and dosage requirement in a thiopurine methyltransferase-deficient child with acute lymphocytic leukemiaThe Journal of Pediatrics, 1991
- Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P45 0IA1 geneFEBS Letters, 1990